EKF has issued an FY22 trading update, with the established Point-of-Care and Central Lab segments growing strongly and ahead of expectations, but growth initiatives coming through slower than forecast. CEO Mike Salter has stepped down, but will remain with the group to focus on delivery of the latter, with Julian Baines returning temporarily as Exec Chair whilst a new permanent CEO is recruited. We pare back our growth expectations in FY23, with additional cost saving measures underway to prote ....

06 Feb 2023
Core ahead of expectations, growth initiatives progressing but more slowly

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Core ahead of expectations, growth initiatives progressing but more slowly
EKF Diagnostics Holdings plc (EKF:LON) | 26.2 0 0.0% | Mkt Cap: 119.0m
- Published:
06 Feb 2023 -
Author:
Chris Glasper -
Pages:
3 -
EKF has issued an FY22 trading update, with the established Point-of-Care and Central Lab segments growing strongly and ahead of expectations, but growth initiatives coming through slower than forecast. CEO Mike Salter has stepped down, but will remain with the group to focus on delivery of the latter, with Julian Baines returning temporarily as Exec Chair whilst a new permanent CEO is recruited. We pare back our growth expectations in FY23, with additional cost saving measures underway to prote ....